feed,title,long_url,short_url
SSRN,‘A Most Equitable Drug’: How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4322653,
SSRN,"COVID-19, Its Variants, and Patent Disclosures",https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4319627,
